Content

Microbial Contamination Control seminar set for Nov. 30

BTEC's fall seminar series wraps up Friday, Nov. 30 when Dr. Lucia Clontz, quality director for Xellia, will speak on microbial contamination control for drug manufacturing. The event will be held at 10:30 a.m. in room 135 at BTEC and is open to all interested persons.

In pharmaceutical/biopharmaceutical production, serious consequences can occur if contamination control is not enforced and contaminated products are released to market. In this presentation, Dr. Clontz will discuss contamination control from the perspectives of quality and regulatory compliance. She'll also discuss the main sources of contamination in drug manufacturing and contamination control strategies.

Xellia is a global specialty injectable pharmaceutical company and a leading provider of anti-infectives such as vancomycin, colistimethate sodium, bacitracin and daptomycin. Corporate headquarters are in Copenhagen, Denmark, and the firm produces products in many locations, including the United States and Europe.